Mefford, I.N., Kincl, L., Dykstra, K.H., Simpson, J.T., Markey, S.P., Dietz, S. and Wightman, R.M., Facile Oxidative Decarboxylation of 3,4-dihydroxyphenylacetic Acid Catalyzed by Copper and Manganese Ions, Biochimica et Biophysica Acta, 1290,224-230, 199
Burnet, P.W., Mefford, I.N., Smith, C.C., Gold, P.W. and Steinberg, E.M., Hippocampal 5-HT1A Receptor Binding Site Densities, 5-HT1A Receptor Messenger Ribonucleic Acid Abundance and Serotonin Levels Parallel the Activity of the Hypothalamic-Pituitary-Adr
Mefford, I.N. and Wade, E.U., Proton pump inhibitors as a treatment method for type II diabetes, Medical Hypotheses, 73, 29-32, 2009.
Mefford. I., Crouch, M.A. and Wade, E., Effect of concomitant proton pump inhibitor therapy on type 2 diabetes control, Family Medicine, 42 (suppl 2), 2010
Crouch, M.A., Mefford, I.N. and Wade, E.U., Proton pump inhibitor therapy associated with lower glycosylated hemoglobin levels in type 2 diabetes, J Am Board Fam Med, 25, 50-54, 2012
Mefford, I.N., Mefford, J.T. and Burris, C.A., Improved diabetes control and pancreatic function in a type 2 diabetic after omeprazole administration, Case Reports in Endocrinology, Volume 2012, Article ID 468609, 2012